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Periodontitis  is  a  multifactorial  disease 
with  microbial  dental  plaque  as  the  initiator  of 
periodontal disease.1 However, the manifestation 
and progression of periodontitis is influenced by a 
wide variety of determinants and factors including 
subject  characteristics,  social  and  behavioral 
factors, systemic factors, genetic factors, tooth-
level  factors,  microbial  composition  of  dental 
plaque and other emerging factors.2
Smoking  is  one  of  the  major  environmental 
risk factors for periodontal diseases.3-11 In studies 
where plaque accumulation was similar in smokers 
and  non-smokers  or  was  adjusted,  current 
smokers  had  deeper  probing  depths,5,6,12-14 
greater  attachment  loss,10,12,13,15  more  bone 
loss,4,11,16 and fewer teeth.13,15 Smokers also exhibit 
more supragingival calculus deposits.17
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AbstrAct
Objectives: The aim of this study was to investigate the effect of cigarette smoking on clinical 
parameters and signs anemia of chronic disease in chronic periodontitis patients.
Methods: The study base consisted of 88 patients with chronic periodontitis including 45 volunteer 
current smokers with age range of 30-69 (45.5±8.5) and 43 volunteer non-smokers with age range 
of 32-61 years (45.8±7.9). The clinical parameters including plaque index (PI), gingival index (GI), 
bleeding on probing (BOP), probing depth (PD), clinical attachment loss (CAL) were recorded and 
several red blood cell parameters were determined from peripheral blood samples. 
Results: In smokers, PI, PD and CAL were significantly higher than non-smokers (P<.05). The 
number of erythrocytes and the levels of hemoglobin, hematocrit and iron were lower in smokers 
compared to non-smokers (P<.05). 
Conclusions: In the present study, it is concluded that cigarette smoking may be effective on the 
signs of anemia of chronic disease in patients with chronic periodontitis. (Eur J Dent 2008;2:102-
109)
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It  is  widely  accepted  that  smoking  impairs 
various  aspects  of  innate  and  immune  host 
responses.18,19  Numerous  functions  of  oral  or 
peripheral  neutrophil  are  negatively  affected 
by  smoking  or  nicotine  exposure,  including 
phagocytosis,20  superoxide  and  hydrogen 
peroxide  generation,21,22  integrin  expression,23 
and protease inhibitor production.24 Alterations in 
gingival crevicular fluid25-27 and peripheral blood 
mononuclear cell28 levels of various cytokines in 
smokers,  tipping  the  balance  in  favor  of  tissue 
breakdown, have been noted.
Until  relatively  recently,  less  attention  has 
been  devoted  to  exploring  the  role  that  chronic 
oral diseases may have on systemic health. The 
hypothesis that oral conditions, such as periodontal 
infections,  may  be  risk  factors  or  indicators 
for  important  medical  outcomes  represents  a 
paradigm shift in thinking about causality and the 
directionality  of  oral  and  systemic  associations. 
The  subgingival  microbiota  in  patients  with 
periodontitis provides a significant and persistent 
gram-negative  bacterial  challenge  to  the  host. 
These  organisms  and  their  products,  such  as 
lipopolysaccharide  (LPS),  have  ready  access  to 
the  periodontal  tissues  and  to  the  circulation 
via  the  sulcular  epithelium,  which  is  frequently 
ulcerated  and  discontinuous.29  It  has  therefore 
been speculated that periodontitis results in a low 
grade systemic inflammation.
Anemia of chronic disease (ACD) is a cytokine-
mediated  anemia  commonly  encountered  in 
clinical practice and characterized by hypoferramia 
with  adequate  reticuloendotelial  iron  stores, 
normal to elevated ferritin concentrations and it is 
a frequent complication of chronic inflammatory 
conditions.30,31  Hutter  et  al32  suggested  that 
periodontitis has chronic and systemic effects and 
that periodontitis may tend towards anemia. 
The  aim  of  present  study  was  to  evaluate 
the  influence  of  cigarette  smoking  on  clinical 




The study population included 88 patients, 45 
smokers and 43 non-smokers in the age range 
of  30-69  (45.5±8.5)  and  32-61  years  (45.8±7.9), 
respectively. The patients had chronic periodontitis 
as evidenced a probing depth of 6 mm or more at 
80% of the proximal sites and bone loss >50% by 
radiographs.33  All  participants  were  in  principal 
periodontally  untreated  and  had  not  previously 
received surgical therapy and were drawn from 
the  patients  with  chronic  periodontitis  at  the 
Department of Periodontology. All subjects were 
systemically  healthy,  with  no  medical  condition 
that would effect their participation in the study. 
An  extensive  medical  history  was  taken  both 
by  a  written  questionnaire  and  by  interview. 
Exclusion criteria applied were a course of anti-
inflammatory or antimicrobial therapy within the 
previous  3  months,  a  history  of  use  of  vitamin 
or  iron  supplementation  within  the  previous  3 
months, and any special dietary requirements (e.g. 
Coeliac disease). Pregnant women and individuals 
who suffered, apart from periodontitis, from any 
given acute or chronic medical condition, including 
diabetes, viral, fungal or bacterial infections, or 
had recent trauma or tooth extractions were also 
excluded. None of them were alcohol consumers. 
The  purpose  and  nature  of  the  study,  including 
the types of clinical measurements and sample 
collection, were explained to all potential subjects. 
After reading and signing the consent form, the 
subjects were enrolled into the study. The study 
was approved by the Medical Ethical Committee of 
our institution.
For  all  participants  smoking  habits  were 
recorded  and  patients  were  classified  as  either 
current smokers [S (+)], i.e., regular daily smoke 
20 cigarettes (45 patients), or non-smokers [S (-)], 
i.e., who had never smoked tobacco (43 patients). 
All  smokers  were  cigarette  smokers.  Smoking 
condition of the patients was calculated as: Number 
of  cigarette  per  day/number  of  years  smoked. 
Patients who have been smoking between 15-20 
years were included in the study. The mean age of 
current smokers and non-smokers was 45.5±8.5 
and  45.8±7.9,  respectively.  The  age  differences 
between groups were not statistically significant 
(P>.05). Body mass index (BMI) measures of the 
patients  were  also  recorded  and  there  was  not 
statistically significant difference between groups 
(P>.05).
Clinical recordings
Supragingival plaque was scored using Plaque 
index (PI)34 Gingival inflammation was scored using 
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Gingival  index  (GI)35  Bleeding  on  probing  (BOP) 
was  measured  dichotomously.36  Probing  depth 
(PD) and clinical attachment level (CAL) measures 
were  obtained  from  the  six  points  of  the  teeth 
using a conventional periodontal probe (Hu-Friedy, 
Chicago, IL, USA). The probe was directed parallel 
to the long axis of the tooth. CAL measurements 
were  made  from  the  cemento-enamel  junction 
to the bottom of the sulcus. All clinical data were 
recorded by one examiner (EOE).
Red blood cell analyses
Venous blood samples were obtained between 
8.30  and  11.00  AM  by  venepuncture  in  the 
antecubital fossa without excessive venous stasis. 
The blood was taken into EDTA containing vacuum 
tubes (HEMA, Germany) in the Faculty of Medicine, 
Department  of  Biochemistry.  The  laboratory 
analysis of differential blood count was performed 
immediately  with  the  Sysmex  XT  2000i  (Roche, 
Switzerland).
In  standardized  and  automated  procedures, 
numbers of erythrocytes, hemoglobin, hematocrit, 
iron, ferritin levels, mean corpuscular volume of 
erythrocytes (MCV), mean corpuscular hemoglobin 
(MCH)  and  the  mean  corpuscular  hemoglobin 
concentration (MCHC) were calculated.
Statistical analysis
Data were expressed as means and standard 
deviations.  The  statistical  significance  of 
differences between groups was tested with Mann 
Whitney  U  Test.  Simple  pair  wise  correlations 
were calculated according to the rank correlation 




The  clinical  characteristics  of  this  study  are 
shown  in  Table  1.  When  the  clinical  parameters 
were compared between groups, in S (+) group, PI, 
PD  and  CAL  were  significantly  higher  compared 
to  S  (-)  (P<.05).  There  were  not  any  differences 
between  smokers  and  non-smokers  in  the  mean 
values of GI and BOP (P>.05). Both study groups had 
a comparable number of teeth present (mean 24.6 
smokers and 24.5 for non-smokers). There were no 
differences between groups with respect to gender.
Serum sample levels of red blood cells
The  mean  values  of  serum  parameters  are 
shown  in  Table  2.  The  number  of  erythrocytes 
and the levels of hemoglobin, hematocrit and iron 
were lower in smokers compared to non-smokers 
(P<.05). The MCV, MCH, MCHC and ferritin levels 
were not different between groups. 
Correlations
Correlations  between  mean  levels  of  serum 
and clinical parameters are shown in Tables 3 and 
4 for S (+) and S (-), respectively. There were no 
significant correlations between the mean levels of 
serum parameters and clinical parameters in S (-) 
group (P>.05). In S (+) group, there were negative 
correlation between CAL and the level of RBC in 
serum  values  (P<.05),  and  positive  correlations 
with  Fe,  MCH  and  MCHC  (P<.01).  In  this  study 
group,  there  were  also  positive  correlations 
between mean PD values and the levels of MCV 
(P<.05), MCH and MCHC in serum (P<.01).
dIscussIon
It is now well established from a large body 
of epidemiologic evidence that cigarette smoking 
is  the  major  preventable  risk  factor  in  the 
incidence  progression  of  periodontal  disease.9,10 
It  is  suggested  that  periodontitis  is  associated 
with  an  increased  risk  for  systemic  diseases 
like  cardiovascular  diseases,  cerebrovascular 
ischemia and atherosclerosis.37 It has been also 
shown  that  periodontitis  patients  have  elevated 
levels of white blood cells, and elevated plasma 
levels  of  C-reactive  protein.38-42  Substantial 
scientific data indicate that the localized infections 
characteristic of periodontitis can have a significant 
effect on the systemic health of both humans and 
animals.43 Just as the periodontal tissues mount 
an  immunoinflammatory  response  to  bacteria 
and their products, systemic challenge with these 
agents also induces a major vascular response. This 
host response may offer explanatory mechanisms 
for the interactions between periodontal infection 
and a variety of systemic disorders.44
In  the  present  study,  smokers  with  chronic 
periodontitis  have  lower  levels  of  hemoglobin, 
hematocrit, iron and number of erythrocytes than 
non-smokers.  Ferritin  levels  were  not  different 
between groups. These findings were in parallel 
direction  of  the  symptoms  of  ACD.  MCV  levels 
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are the main determinants of the some kinds of 
anemia. A depressed level of MCV (microcytosis) 
relates  anemia  to  iron  deficiency  and  elevated 
level  of  MCV  (macrocytosis)  relates  anemia  to 
vitamin  deficiency.45,46  In  our  study,  MCV  levels 
were  between  the  reference  values,  as  mostly 
seen in ACD and called as normocytosis.
It has been proposed that hepcidin is a primary 
factor in the pathogenesis of the ACD, a cytokine-
mediated  anemia  commonly  encountered 
in  clinical  practice  and  characterized  by 
hypoferraemia with adequate reticuloendothelial 
iron  stores.31  Previous  studies  indicated  that 
IL-6 mediates hepcidin increase and consequent 
hypoferremia during inflammation.47 It was found 
that hepcidin mRNA was increased in the livers 
of  lipopolysaccharide  (LPS)-treated  mice  and 
LPS-treated  hepatocytes.48  This  also  suggested 
that  hepcidin  could  be  the  pathogenic  mediator 
of ACD. Kemna et al49 showed the importance of 
IL-6-hepcidin axis in development of hypoferremia 
in  inflammation  and  highlight  the  rapid 
responsiveness  of  this  iron  regulatory  system. 
Nemeth et al50 found that patients with ACD due 
to  inflammatory  disorders  or  infections  had 
markedly increased excretion of urinary hepcidin. 
In vitro stimulation of fresh human hepatocytes 
with a panel of cytokines showed strong induction 
of hepcidin mRNA by IL-6, but not IL-α or TNF-α, 
indicating  that  IL-6  may  be  the  mediator  of 
hepcidin  induction  by  inflammation.  Although 
there  aren’t  any  studies  about  the  relationship 
between hepcidin and periodontal diseases or the 
effect of smoking on hepcidin, it is well known that 
pro-inflammatory  cytokines  and  mediators  are 
significantly elevated, with gingival inflammation 
during  the  destructive  phase  of  periodontitis.51-
56  There  is  also  strong  evidence  for  cytokines 
eliciting  the  systemic  acute-phase  response  in 
various chronic inflammatory diseases.57,58 Hutter 
et al32 suggested that periodontitis also needs to be 
considered as a chronic disease which may cause 
lower numbers of erythrocytes and consequently 
lower  hemoglobin  levels.  They  mentioned  that 
the pathogenesis for their findings is similar as 
reported for rheumatoid arthritis, i.e. depressed 






Table 1. The mean values of clinical parameters (mean ± SD).
PI: Plaque index, GI: Gingival index, BOP: Bleeding on probing, PD: Pocket depth, CAL: Clinical attachment loss 
*:P<.05 according to Mann Whitney U Test
Parameters S (+) (n=45) S (-) (n=43)
RBC (106/µl) 4.88±0.48* 5.17±0.47
HGB (g/dl) 13.48±2.19* 14.98±1.58
HCT (%) 41.39±5.47* 45.17±3.84
FE (µg/dl) 78.37±38.62* 97.76±39.38
FER (ng/dl) 82.16±49.43 81.39±86.47
MCV (fl) 87.32±3.83 84.67±7.38
MCH (pg) 28.97±2.64 27.55±3.58
MCHC (g/dl) 33.18±2.08 32.48±2.44
RBC: Red blood cell, HGB: Hemoglobin, HCT: Hematocrit, FE: Iron, FER: Ferritin MCV: Mean corpuscular volume of erythrocytes, 
MCH: Mean corpuscular hemoglobin, MCHC: Mean corpuscular hemoglobin concentration 
*:P<.05 according to Mann Whitney U Test
Table 2. The mean values of serum parameters in S (+) and S (-) (mean ± SD).European Journal of Dentistry
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erythropoiesis  by  systemically  circulating  pro-
inflammatory  cytokines  resulting  from  a  local 
chronic inflammatory process. 
Tobacco  components  may  also  modify  the 
production of cytokines or inflammatory mediators. 
In smokers an imbalance in cytokine production 
seems to occur. Elevated concentrations of IL-6 
were observed in the plasma of smokers,59 as well 
as in the alveolar cells of healthy donors stimulated 
by tobacco glycoprotein.60 Nicotine, one of the most 
deleterious products of cigarette, has been shown 
to  increase  release  of  IL-6  by  cultured  murine 
osteoblasts.61 Giannopoulou et al26 indicated that 
smoking interferes with cytokine production. It has 
also been reported that release of cytokines from 
peripheral  neutrophils  and  various  parameters 
of  inflammation  in  plasma  seem  to  be  affected 
more  by  cigarette  smoking  than  periodontal 
disease.62 Such alterations in host response may 
affect  the  reparative  and  regenerative  potential 
of  the  periodontium  in  tobacco  smokers.  In  the 
literature it has been identified that smoking is an 
important factor to affect erythrocytes and related 
parameters.63,64 In the present study, our first aim 
was  to  detect  the  effect  of  smoking  on  ACD  in 
the existence of chronic periodontitis. Therefore, 
we did not analyze the inflammatory mediators. 
But further studies are needed that support the 
findings of our study with these measurements. 
The  current  study  indicates  periodontitis  also 
needs to be considered as a chronic disease and 
together  with  the  effect  of  cigarette  smoking  it 
may cause lower numbers of erythrocytes and the 
levels of hemoglobin, hematocrit and iron.
The BMI measures were also collected due to 
well recognized effect of adiposity on systemic host 
response.65,66  Nishida  et  al67  suggested  that  the 
immunological  disorders  or  inflammation  might 
be the reason that obese smokers tend to exhibit 
escalating poor periodontal status relative to non-
obese  and  non-smoking  individuals.  Because  of 
that obese patients were excluded from the study 
Parameters PI GI BOP PD CAL
RBC (106/µl) 0.045 -0.125 -0.217 -0.188 -0.320*
HGB (g/dl) 0.053 -0.005 0.071 -0.099 0.134
HCT (%) 0.036 -0.175 -0.132 -0.062 -0.215
FE (µg/dl) -0.083 0.069 0.243 0.186 0.331
FER (ng/dl) -0.060 0.026 0.031 0.192 0.147
MCV (fL) 0.040 -0.045 0.253 0.302* 0.277
MCH (pg) 0.087 0.177 -0.099 0.599** 0.525**
MCHC (g/dl) 0.053 0.277 -0.109 0.609** 0.540**
*: The correlation at P<.05 level (Pearson correlation coefficients).
**: The correlation at P<.01 level (Pearson correlation coefficients).
Table 3. Correlations between serum and clinical parameters in S (+) (n=45).
Parameters PI GI BOP PD CAL
RBC (106/µl) 0.155 -0.020 -0.031 -0.139 -0.068
HGB (g/dl) 0.129 -0.105 0.074 -0.069 0.003
HCT (%) 0.086 -0.167 -0.078 -0.224 -0.162
FE (µg/dl) 0.079 -0.128 0.227 -0.018 -0.026
FER (ng/dl) -0.041 -0.094 0.147 -0.079 0.046
MCV (fl) -0.038 -0.236 -0.068 -0.176 -0.168
MCH (pg) 0.049 -0.126 0.122 0.024 0.050
MCHC (g/dl) 0.133 0.041 0.290 0.229 0.258
Table 4. Correlations between serum and clinical parameters in S (-) (n=43).
*: The correlation at P<.05 level (Pearson correlation coefficients).
**: The correlation at P<.01 level (Pearson correlation coefficients).
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and also the difference between the groups was 
not significant.
Some  of  the  studies  interpreted  the  effect 
of  cigarette  smoking  on  the  periodontium  to 
be indirect and due to inadequate levels of oral 
hygiene  and  increased  plaque  accumulation 
among smokers relative to non-smokers.12,68,69 In 
this study, PI levels of S (+) were higher than S (-).
The  studies  searching  the  effect  of  smoking 
on clinical parameters suggest that non-smokers 
have higher GI and BOP values than smokers.3,6,15 
But, there are conflicting results those show no 
significant difference between smokers and non-
smokers70 and smokers have higher values than 
non-smokers.71  Pucher  et  al72  reported  that  GI 
and BOP values were similar in smokers and non-
smokers 9 months after periodontal therapy. In 
this study, GI and BOP values were found similar in 
smokers and non-smokers. However, the effects 
of  nicotine  has  been  disputed,  some  claim  that 
the blood flow is reduced73 and others claim it is 
significantly increased74 or unchanged.75
The studies which show that PD values were 
higher  in  smokers  than  non-smokers  are  also 
present  in  literature.3,5,12,16,69,70,76,77  A  significant 
positive  correlation  has  been  shown  between 
smoking and CAL.11,15,69,70,77,78 In the present study, 
PD and CAL values were also higher in S (+) than S 
(-). The reason of increased PD and CAL levels in 
smokers may be depend on accumulation of dental 
plaque and poor oral hygiene.68,69,79 In S (+) group, 
it  was  found  negative  correlation  between  CAL 
and the level of RBC in serum values and positive 
correlations with MCH and MCHC. In this study 
group, it was found positive correlations between 
mean PD values and the levels of MCV, MCH and 
MCHC in serum. According to the results of this 
study, it seems that smoking is an important factor 
to affect erythrocytes and related parameters.
concLusIons
From the results of the present study, it can be 
stated that cigarette smoking could have an effect 
on  the  numbers  of  erythrocytes  and  the  levels 
of  hemoglobin  hematocrit  and  iron  in  serum. 
Additionally,  although  cigarette  smoking  does 
not  affect  the  degree  of  gingival  inflammation, 
the amount of dental plaque, probing depth and 
clinical attachment loss were higher in smokers.
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